MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.54 -0.04 (1.12%)
Previous Close $3.58    52 Week High $2.51 
Open $3.59    52 Week Low $0.41 
Day High $3.62    P/E N/A 
Day Low $3.50    EPS $-0.64 
Volume 5,513,382       

Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.54 -0.04 (1.12%)
Previous Close $3.58    52 Week High $2.51 
Open $3.59    52 Week Low $0.41 
Day High $3.62    P/E N/A 
Day Low $3.50    EPS $-0.64 
Volume 5,513,382